#FORTEStudy is on YouTube!
11/09/2022
Watch the video aimed towards medical professionals and research staff today!
The NRG-CC005 team recorded a video at the NRG Summer meeting in June of 2022 to answer the question: “Why would your site want to be a part of the FORTE Clinical Trial?” We encourage site staff to distribute this internally to encourage participation at your institution among research professionals in the conduct of the FORTE trial. You could send the link to this video to:
- Physicians (especially GI doctors), nurse practitioners, registered nurses
- Investigators
- Research nurses
- Research coordinators/associates
- Research assistants
Watch now: https://youtu.be/eF8BDkt9tNU!
NOTE: This video is not IRB-approved for patient use.
Accrual Updates and Milestones (as of October 31, 2022)
Top accruing sites:
- Kaiser Permanente – Vallejo – 96 accrued
- UPMC-Presbyterian Hospital – 61 accrued
- Park Nicollet Clinic – Saint Louis Park – 50 accrued
Most recent randomizations:
- Park Nicollet Clinic – Saint Louis Park – October 31, 2022
- Spectrum Health Reed City Hospital – October 31, 2022
- Kaiser Permanente – Vallejo – October 31, 2022
Thanks to your recruitment efforts, FORTE has accrued over 200 participants in just a few months! 8 activated sites accrued participants in October 2022. Keep up the good work!
Encourage your sites to interact with #FORTEStudy on social media!
LinkedIn: https://www.linkedin.com/company/forte-study
Twitter: https://twitter.com/fortestudy
Facebook: https://www.facebook.com/FORTEStudy
Instagram: https://www.instagram.com/fortestudy/
YouTube: https://www.youtube.com/channel/UCFev2CwLP14a9cocgmmM4Hg
Questions from Site Research Staff
If research staff have questions about a patient’s eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:
1(800) 477-7227
BackSupport NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More